These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32829303)

  • 1. Brolucizumab: the road ahead.
    Sharma A; Kumar N; Bandello F; Kuppermann BD; Loewenstein A; Regillo CD
    Br J Ophthalmol; 2020 Dec; 104(12):1631-1632. PubMed ID: 32829303
    [No Abstract]   [Full Text] [Related]  

  • 2. Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.
    Bloch SB; Larsen M
    Acta Ophthalmol; 2015 Mar; 93(2):103-4. PubMed ID: 25688486
    [No Abstract]   [Full Text] [Related]  

  • 3. Retinal Vasculitis After Administration of Brolucizumab Resulting in Severe Loss of Visual Acuity.
    Kondapalli SSA
    JAMA Ophthalmol; 2020 Oct; 138(10):1103-1104. PubMed ID: 32761135
    [No Abstract]   [Full Text] [Related]  

  • 4. Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration.
    Nguyen QD; Das A; Do DV; Dugel PU; Gomes A; Holz FG; Koh A; Pan CK; Sepah YJ; Patel N; MacLeod H; Maurer P
    Ophthalmology; 2020 Jul; 127(7):963-976. PubMed ID: 32107066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
    Baumal CR; Spaide RF; Vajzovic L; Freund KB; Walter SD; John V; Rich R; Chaudhry N; Lakhanpal RR; Oellers PR; Leveque TK; Rutledge BK; Chittum M; Bacci T; Enriquez AB; Sund NJ; Subong ENP; Albini TA
    Ophthalmology; 2020 Oct; 127(10):1345-1359. PubMed ID: 32344075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.
    Hasler PW; Bloch SB; Villumsen J; Fuchs J; Lund-Andersen H; Larsen M
    Acta Ophthalmol; 2015 Mar; 93(2):122-5. PubMed ID: 25403735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema.
    Rahimy E; Sarraf D
    Arch Ophthalmol; 2012 Jul; 130(7):931-2. PubMed ID: 22776935
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance.
    Woo SJ; Han JM; Ahn J; Heo JW; Yu HG; Chung H; Song J; Park KU; Park KH
    Retina; 2012 Apr; 32(4):667-71. PubMed ID: 22307220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.
    Caruso A; Füth M; Alvarez-Sánchez R; Belli S; Diack C; Maass KF; Schwab D; Kettenberger H; Mazer NA
    Mol Pharm; 2020 Feb; 17(2):695-709. PubMed ID: 31876425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change of retinal nerve fiber layer thickness in various retinal diseases treated with multiple intravitreal antivascular endothelial growth factor.
    Shin HJ; Shin KC; Chung H; Kim HC
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2403-11. PubMed ID: 24609624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pain in intravitreal bevacizumab injections.
    Moisseiev E; Regenbogen M; Bartfeld Y; Barak A
    Curr Eye Res; 2012 Sep; 37(9):813-7. PubMed ID: 22667326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy.
    Finger PT; Mukkamala SK
    Eur J Ophthalmol; 2011; 21(4):446-51. PubMed ID: 21218391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal anti-VEGF therapy for retinal macroaneurysm.
    Zweifel SA; Tönz MS; Pfenninger L; Becker M; Michels S
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):392-5. PubMed ID: 23629789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angled transscleral intravitreal injection: a crossover study.
    Mehta MC; Finger PT
    Eur J Ophthalmol; 2015; 25(2):173-6. PubMed ID: 25384968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of intravitreal injections in patients with diabetes.
    Shikari H; Silva PS; Sun JK
    Semin Ophthalmol; 2014; 29(5-6):276-89. PubMed ID: 25325853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK
    Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System.
    Wykoff CC; Hariprasad SM; Zhou B
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):913-917. PubMed ID: 30566697
    [No Abstract]   [Full Text] [Related]  

  • 18. Brolucizumab (Beovu) for age-related macular degeneration.
    Med Lett Drugs Ther; 2020 Feb; 62(1591):23-24. PubMed ID: 32022789
    [No Abstract]   [Full Text] [Related]  

  • 19. Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV).
    Shiroma HF; Farah ME; Takahashi WY; Gomes AM; Goldbaum M; Rodrigues EB
    Arq Bras Oftalmol; 2015; 78(1):32-5. PubMed ID: 25714535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms.
    Pichi F; Morara M; Torrazza C; Manzi G; Alkabes M; Balducci N; Vitale L; Lembo A; Ciardella AP; Nucci P
    Am J Ophthalmol; 2013 Feb; 155(2):287-294.e1. PubMed ID: 23111179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.